Cargando…
Answers to burning questions for clinical allergologists related to the new COVID-19 vaccines
BACKGROUND: Along with the newly approved vaccines against coronavirus disease 2019 (COVID-19), first reports of allergic or intolerance reactions were published. Subsequently, questions arose whether these vaccines pose an increased risk for intolerance reactions and whether allergic patients may b...
Autores principales: | Altrichter, Sabine, Wöhrl, Stefan, Horak, Fritz, Idzko, Marco, Jordakieva, Galateja, Untersmayr, Eva, Szepfalusi, Zsolt, Zieglmayer, Petra, Jensen-Jarolim, Erika, Wiedermann, Ursula, Rosenkranz, Alexander, Hötzenecker, Wolfram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Medizin
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278365/ https://www.ncbi.nlm.nih.gov/pubmed/34277326 http://dx.doi.org/10.1007/s40629-021-00177-3 |
Ejemplares similares
-
Antworten auf brennende Fragen an klinische Allergolog*innen im Zusammenhang mit den neuen COVID-19-Impfstoffen
por: Altrichter, Sabine, et al.
Publicado: (2021) -
Sublingual house dust mite immunotherapy has no impact on decrease of circulating erythrocytes upon airway allergen challenge in allergic rhinitis
por: Jordakieva, Galateja, et al.
Publicado: (2017) -
Country-wide medical records infer increased allergy risk of gastric acid inhibition
por: Jordakieva, Galateja, et al.
Publicado: (2019) -
Reply to “Acid inhibitors and allergy: comorbidity, causation and confusion”
por: Jensen-Jarolim, Erika, et al.
Publicado: (2020) -
The impact of allergen exposure and specific immunotherapy on circulating blood cells in allergic rhinitis
por: Jordakieva, Galateja, et al.
Publicado: (2018)